Jose Alvarez-Cardona

Medicine & Life Sciences

1. Amyloidosis 100%
2. olaratumab 58%
3. Cardiotoxicity 48%
4. Dexrazoxane 47%
5. Amyloidosis, Hereditary, Transthyretin-Related 46%
6. Heart Failure 41%
7. Anthracyclines 37%
8. Coronavirus 37%
9. Neoplasms 36%
10. Hepatocyte Growth Factor 35%
11. Pandemics 31%
12. Cardiology 29%
13. Patient Care 28%
14. Sarcoma 28%
15. Doxorubicin 27%
16. Light 26%
17. Therapeutics 26%
18. Cardiovascular Diseases 25%
19. Magnetic Resonance Spectroscopy 25%
20. Primary Health Care 23%
21. Second Primary Neoplasms 22%
22. Translational Medical Research 22%
23. Radiation 22%
24. Cancer Survivors 21%
25. Radiotherapy 20%
26. Education 18%
27. Transplants 18%
28. Progression-Free Survival 18%
29. Blood Vessels 17%
30. Population 15%
31. Oncologists 14%
32. Scope of Practice 13%
33. Mortality 13%
34. Survival 12%
35. Severe Acute Respiratory Syndrome 12%
36. Biomarkers 11%
37. Morbidity 11%
38. Epidemiology 11%
39. Vacuum 11%
40. Left Ventricular Hypertrophy 10%
41. Clinical Decision-Making 10%
42. Ionizing Radiation 10%
43. Drug Therapy 10%
44. Vascular Diseases 9%
45. Practice Guidelines 9%
46. Prealbumin 9%
47. Disease Outbreaks 8%
48. Early Diagnosis 8%
49. Risk Assessment 8%
50. Atherosclerosis 8%